Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HuMax-CD4 in Advanced Cutaneous T-cell Lymphoma
NCT00071084Phase 2Completed
- Sponsor
- Genmab
- Start
- May 2003
- Primary completion
- Jun 2004
- Modality
- Monoclonal Antibodies
- Countries
- 4
01
Overview
A Phase 2 trial of zanolimumab in cutaneous T-cell lymphoma (CTCL), sponsored by Genmab. Started May 2003; status: completed.
02
Drugs
zanolimumab
03
Conditions
cutaneous T-cell lymphoma (CTCL)
Beyond the preview
Go deeper on NCT00071084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00071084.